Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease

American Journal of Cardiology

Volumn 88, Issue 7 SUPPL. 2, 2001, Pages 43-47

  Criqui, Michael H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CILOSTAZOL; PENTOXIFYLLINE; PLACEBO;

AGE; ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE MARKER; DRUG EFFICACY; DYSLIPIDEMIA; EXERCISE; HUMAN; INTERMITTENT CLAUDICATION; LIPID BLOOD LEVEL; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING CESSATION; SYMPTOM; TREATMENT OUTCOME; UNITED STATES;

EID: 0035846023     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01881-1     Document Type: Article

References (29)

1. Epidemiology
2. The prevalence of peripheral arterial disease in a defined population
3. Peripheral arterial disease in the elderly: The Rotterdam Study
4. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study
5. Indirect systolic pressures and pulse waves in arterial occlusive diseases of the lower extremities
6. Ankle systolic pressure measurements in arterial disease affecting the lower extremities
7. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease
8. Lower extremity arterial disease in elderly subjects with systolic hypertension
9. Resting and treadmill electrocardiographic findings in patients with intermittent claudication
10. Selection of patients for preoperative coronary angiography: Use of dipyridamole-stress-thallium myocardial imaging
11. Coronary artery disease is highly prevalent among patients with premature peripheral vascular disease
12. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management
13. Intermittent claudication: Factors determining outcome
14. Autogenous vein grafting in femoropopliteal atherosclerosis: The limits of its effectiveness
15. Life expectancy following aortofemoral arterial grafting
16. Postoperative stroke in cardiac and peripheral vascular disease
17. Carotid artery stenosis in peripheral vascular disease
18. Mortality over a period of 10 years in patients with peripheral arterial disease
19. The ratio of ankle and arm arterial pressure as an independent predictor of mortality
20. Management of chronic ischemia of the lower extremities. Introduction and general consideration
21. Exercise training and peripheral vascular disease
22. Exercise for intermittent claudication
23. Cilostazol
24. Effects of colestipol-niacin therapy on human femoral atherosclerosis
25. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
26. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of Hyperlipidemias
27. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)
28. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease